{
  "meta": {
    "title": "23_Diseases_Of_Parathyroid",
    "url": "https://brainandscalpel.vercel.app/23-diseases-of-parathyroid-26525a28.html",
    "scrapedAt": "2025-11-30T06:57:07.094Z"
  },
  "questions": [
    {
      "id": 90583,
      "choices": [
        {
          "id": 212979,
          "text": "Parathyroid adenoma"
        },
        {
          "id": 212980,
          "text": "Chief cell hyperplasia"
        },
        {
          "id": 212981,
          "text": "Multiple adenoma"
        },
        {
          "id": 212982,
          "text": "Parathyroid carcinoma"
        }
      ],
      "text": "Most common cause of primary hyperparathyroidism is",
      "unique_key": "Q5868022",
      "question_audio": null,
      "question_video": null,
      "map_id": 34586558,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Parathyroid adenoma. The most common cause of primary hyperparathyroidism is a parathyroid adenoma, which accounts for about 80-85% of cases. A parathyroid adenoma is a benign tumor of the parathyroid gland that leads to excessive production of parathyroid hormone (PTH), causing increased calcium levels in the blood (hypercalcemia). This condition is most commonly seen in individuals over 50 years of age and is typically diagnosed when blood tests reveal elevated calcium and PTH levels. Incorrect Answers B. Chief cell hyperplasia This option is incorrect because chief cell hyperplasia (also referred to as parathyroid hyperplasia) is responsible for 10-15% of primary hyperparathyroidism cases, making it less common than parathyroid adenomas. It involves the enlargement and increased activity of all four parathyroid glands rather than the formation of a single tumor. This condition may occur in familial cases or in association with other conditions like MEN1 (multiple endocrine neoplasia type 1). C. Multiple adenoma This option is incorrect because multiple adenomas are a rare cause of primary hyperparathyroidism. They account for only about 2-5% of cases. Multiple parathyroid adenomas involve more than one of the parathyroid glands, leading to hypercalcemia and elevated PTH levels. However, this is far less common than a single parathyroid adenoma. D. Parathyroid carcinoma This option is incorrect because parathyroid carcinoma is a very rare cause of primary hyperparathyroidism, accounting for less than 1% of cases. Parathyroid carcinoma can cause severe hypercalcemia and elevated PTH levels, but it is much less common than adenomas and is typically associated with more aggressive clinical presentations. Diagnosis is often challenging, and surgery is the primary treatment for this condition.",
      "correct_choice_id": 212979,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42225251704443833/42225251704443833.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42225251704443833/42225251704443833.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90584,
      "choices": [
        {
          "id": 212983,
          "text": "Hypercalcemia"
        },
        {
          "id": 212984,
          "text": "Hyperphosphatemia"
        },
        {
          "id": 212985,
          "text": "Increased c-AMP in urine"
        },
        {
          "id": 212986,
          "text": "Decreased hydroxyproline in urine"
        }
      ],
      "text": "Which of the following is associated with secondary hyperparathyroidism due to dietary deficiency of calcium?",
      "unique_key": "Q7853386",
      "question_audio": null,
      "question_video": null,
      "map_id": 34947233,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Increased c-AMP in urine. In secondary hyperparathyroidism, which can result from a dietary deficiency of calcium, there is compensatory hyperplasia of the parathyroid glands due to low calcium levels. To compensate for the hypocalcemia, the parathyroid glands increase their secretion of parathyroid hormone (PTH). Elevated PTH levels lead to increased renal cAMP production, which results in increased excretion of cAMP in the urine. The elevated cAMP levels in the urine are a characteristic feature of secondary hyperparathyroidism due to calcium deficiency and renal involvement. Incorrect Answers A. Hypercalcemia This option is incorrect because hypercalcemia is not typically associated with secondary hyperparathyroidism due to dietary calcium deficiency. In secondary hyperparathyroidism, the calcium levels are usually low or normal due to insufficient dietary calcium intake, leading to the parathyroid glands compensating by producing more PTH. Hypercalcemia generally occurs in primary hyperparathyroidism when there is excessive PTH production. B. Hyperphosphatemia This option is incorrect because hyperphosphatemia is not directly caused by dietary calcium deficiency. However, in the context of secondary hyperparathyroidism, particularly in patients with chronic kidney disease (CKD), phosphate levels can increase due to impaired renal clearance. While dietary calcium deficiency can stimulate PTH release, the increase in phosphate levels is more commonly a result of kidney dysfunction rather than calcium deficiency alone. D. Decreased hydroxyproline in urine This option is incorrect because hydroxyproline is a marker for bone resorption and is typically increased in conditions with excessive bone turnover, such as hyperparathyroidism. In secondary hyperparathyroidism, due to calcium deficiency or vitamin D deficiency, there is increased bone resorption, which would lead to an increase, not a decrease, in hydroxyproline levels in urine. Therefore, decreased hydroxyproline is not a characteristic finding in secondary hyperparathyroidism due to dietary calcium deficiency.",
      "correct_choice_id": 212985,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75129181704444111/75129181704444111.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75129181704444111/75129181704444111.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90585,
      "choices": [
        {
          "id": 212987,
          "text": "Primary hyperparathyroidism"
        },
        {
          "id": 212988,
          "text": "Secondary hyperparathyroidism due to vitamin D deficiency"
        },
        {
          "id": 212989,
          "text": "Malignancy with lytic bone lesions"
        },
        {
          "id": 212990,
          "text": "Osteoporosis"
        }
      ],
      "text": "Increased calcium with decreased phosphate levels are seen in ?",
      "unique_key": "Q4448951",
      "question_audio": null,
      "question_video": null,
      "map_id": 34288348,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Primary hyperparathyroidism. In primary hyperparathyroidism, there is excessive secretion of parathyroid hormone (PTH) due to a parathyroid adenoma or hyperplasia, which leads to increased calcium levels (hypercalcemia) and decreased phosphate levels (hypophosphatemia). The increase in PTH stimulates the release of calcium from bones into the bloodstream, while at the same time, it decreases the renal excretion of calcium and increases phosphate excretion, which results in low phosphate levels. Thus, the hallmark of primary hyperparathyroidism is elevated calcium and decreased phosphate. Incorrect Answers B. Secondary hyperparathyroidism due to vitamin D deficiency This option is incorrect because in secondary hyperparathyroidism due to vitamin D deficiency, there is low calcium in the blood (hypocalcemia), which triggers an increase in PTH production. In response to this, phosphate levels typically increase due to the reduction in renal excretion of phosphate caused by elevated PTH. Therefore, secondary hyperparathyroidism due to vitamin D deficiency is more likely to present with low calcium and high phosphate, not the opposite. C. Malignancy with lytic bone lesions This option is incorrect because in malignancy with lytic bone lesions (for example, in multiple myeloma or metastatic cancer), calcium levels can be elevated due to bone resorption. However, phosphate levels are usually normal or low because the destruction of bone tissue leads to the release of calcium, but not necessarily phosphate. In some cases, the phosphate level may actually be low due to the increase in renal excretion caused by high calcium levels. D. Osteoporosis This option is incorrect because osteoporosis is a condition of decreased bone density due to an imbalance between bone resorption and bone formation, but it does not affect serum calcium and phosphate levels directly. In osteoporosis, calcium and phosphate levels are typically normal as the condition does not involve excess PTH secretion, unlike primary hyperparathyroidism, where elevated calcium and low phosphate are key features.",
      "correct_choice_id": 212987,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51898671704444179/51898671704444179.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51898671704444179/51898671704444179.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90586,
      "choices": [
        {
          "id": 212991,
          "text": "Aluminium intoxication"
        },
        {
          "id": 212992,
          "text": "Secondary hyperparathyroidism"
        },
        {
          "id": 212993,
          "text": "Osteoporosis"
        },
        {
          "id": 212994,
          "text": "Osteomalacia"
        }
      ],
      "text": "A 40 year old man known case of chronic renal failure develops rugger jersey spine. The probable cause is-",
      "unique_key": "Q1752500",
      "question_audio": null,
      "question_video": null,
      "map_id": 34393450,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Secondary hyperparathyroidism. Rugger jersey spine is a radiological finding that is associated with secondary hyperparathyroidism, which commonly occurs in chronic renal failure. In this condition, the kidneys are unable to properly excrete phosphate, leading to hyperphosphatemia. This in turn causes a drop in calcium levels (hypocalcemia), which stimulates the parathyroid glands to secrete more parathyroid hormone (PTH). The elevated PTH causes bone resorption and changes the appearance of the vertebrae, resulting in the \"rugger jersey spine\" sign—a characteristic pattern on X-ray where the vertebrae show sclerosis of the upper and lower endplates with a lucent zone in between. This is a common finding in patients with chronic kidney disease and secondary hyperparathyroidism. Incorrect Answers A. Aluminium intoxication Aluminium toxicity can cause osteomalacia, but it is not typically associated with the rugger jersey spine appearance. Instead, aluminium toxicity can lead to bone pain and softened bones, and it can contribute to a different type of bone abnormality, such as osteomalacia, which can present with generalized bone pain and weakness. The rugger jersey spine is not characteristic of aluminium intoxication. C. Osteoporosis Osteoporosis involves low bone mass and can lead to fractures, but it does not typically result in rugger jersey spine. In osteoporosis, the bone density decreases uniformly without the characteristic sclerosis seen in the endplates. Although osteoporosis can occur in patients with chronic kidney disease, it does not specifically cause the appearance seen in rugger jersey spine. D. Osteomalacia Osteomalacia involves the softening of bones due to defective mineralization, typically due to vitamin D deficiency or other mineral imbalances. While osteomalacia can cause generalized bone pain, it does not lead to the distinctive rugger jersey spine radiographic finding. In osteomalacia, bone deformities or fractures may be present, but the radiographic appearance of rugger jersey spine is specific to secondary hyperparathyroidism due to chronic kidney disease.",
      "correct_choice_id": 212992,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32948181704444190/32948181704444190.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32948181704444190/32948181704444190.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90587,
      "choices": [
        {
          "id": 212995,
          "text": "Osteopetrosis"
        },
        {
          "id": 212996,
          "text": "Osteoporosis"
        },
        {
          "id": 212997,
          "text": "Cysts"
        },
        {
          "id": 212998,
          "text": "Brown tumor"
        }
      ],
      "text": "In hyperparathyroidism all are seen in except",
      "unique_key": "Q3701964",
      "question_audio": null,
      "question_video": null,
      "map_id": 34518094,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Osteopetrosis. Osteopetrosis is a condition characterized by excessive bone density and impaired bone resorption, typically due to a defect in osteoclast function. It is not seen in hyperparathyroidism. In fact, hyperparathyroidism typically results in bone resorption, leading to conditions like osteoporosis and brown tumors, which are opposite to the bone changes seen in osteopetrosis. Therefore, osteopetrosis is not associated with hyperparathyroidism. Incorrect Answers B. Osteoporosis Osteoporosis is a common finding in hyperparathyroidism, particularly in primary hyperparathyroidism. Elevated levels of parathyroid hormone (PTH) lead to increased bone resorption, resulting in decreased bone density. This loss of bone mass contributes to osteoporosis, a condition where bones become weak and more prone to fractures. C. Cysts Bone cysts can also occur in hyperparathyroidism, specifically in the form of osteitis fibrosa cystica, which is a condition characterized by bone cysts and fibrous tissue replacement of bone due to excessive PTH secretion. These cysts are commonly seen in primary hyperparathyroidism as a result of the continuous bone resorption and remodeling process. D. Brown tumor Brown tumors are another hallmark of hyperparathyroidism, especially in primary hyperparathyroidism. These are not true tumors, but localized accumulations of fibrous tissue, hemorrhage, and osteoclasts in response to excessive PTH activity. The term \"brown\" comes from the brownish color of the lesions due to hemorrhage and hemosiderin deposits. These tumors are typically found in the long bones, spine, and jaw.",
      "correct_choice_id": 212995,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61141391704444218/61141391704444218.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61141391704444218/61141391704444218.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90588,
      "choices": [
        {
          "id": 212999,
          "text": "Increased serum calcium"
        },
        {
          "id": 213000,
          "text": "Low urinary calcium"
        },
        {
          "id": 213001,
          "text": "Increased PTH"
        },
        {
          "id": 213002,
          "text": "Increased C-AMP"
        }
      ],
      "text": "Primary hyperparathyroidism is suggested by all of the following except",
      "unique_key": "Q9778081",
      "question_audio": null,
      "question_video": null,
      "map_id": 34005777,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Low urinary calcium. In primary hyperparathyroidism, high serum calcium is typically seen due to excessive secretion of parathyroid hormone (PTH), which leads to increased bone resorption, calcium release, and renal tubular calcium reabsorption. As a result, there is generally increased urinary calcium excretion (not low) because the kidneys attempt to excrete excess calcium to maintain normal calcium levels in the blood. Therefore, low urinary calcium would not be a typical finding in primary hyperparathyroidism. Incorrect Answers A. Increased serum calcium Increased serum calcium is a hallmark of primary hyperparathyroidism. The increased secretion of PTH leads to increased calcium release from bones and enhanced calcium reabsorption in the kidneys. Consequently, the serum calcium levels rise, which is one of the main diagnostic features of the condition. C. Increased PTH Increased PTH is the central feature of primary hyperparathyroidism. The parathyroid glands produce too much parathyroid hormone in this condition, usually due to a benign adenoma or hyperplasia of the parathyroid glands. This excess PTH leads to the increased release of calcium from the bones, decreased calcium excretion by the kidneys, and increased calcium levels in the blood. D. Increased C-AMP Increased cAMP (cyclic adenosine monophosphate) in the urine is a common finding in primary hyperparathyroidism. Elevated PTH stimulates the production of cAMP in the renal tubules. The measurement of urinary cAMP is used as a diagnostic marker, as cAMP levels increase in response to excessive PTH activity.",
      "correct_choice_id": 213000,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78928361704444230/78928361704444230.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78928361704444230/78928361704444230.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90589,
      "choices": [
        {
          "id": 213003,
          "text": "Hyperparathyroidism"
        },
        {
          "id": 213004,
          "text": "Hypoparathyroidism"
        },
        {
          "id": 213005,
          "text": "Hyperthyroidism"
        },
        {
          "id": 213006,
          "text": "Hypothyroidism"
        }
      ],
      "text": "Low calcium and high phosphate is seen in-",
      "unique_key": "Q7195820",
      "question_audio": null,
      "question_video": null,
      "map_id": 34702768,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hypoparathyroidism. In hypoparathyroidism, there is a deficiency of parathyroid hormone (PTH), which is essential for maintaining normal calcium and phosphate balance. PTH normally increases calcium levels by promoting calcium release from bones, enhancing calcium reabsorption in the kidneys, and increasing calcium absorption from the intestines. When PTH is deficient (as in hypoparathyroidism), serum calcium levels decrease, and phosphate levels increase because the kidneys fail to excrete phosphate appropriately. As a result, low calcium and high phosphate are characteristic findings in hypoparathyroidism. Incorrect Answers A. Hyperparathyroidism In hyperparathyroidism, the parathyroid glands secrete too much PTH, which leads to increased calcium levels (due to increased bone resorption and renal calcium reabsorption) and decreased phosphate levels (due to increased renal phosphate excretion). Therefore, in hyperparathyroidism, you would expect high calcium and low phosphate, not the reverse. C. Hyperthyroidism Hyperthyroidism is characterized by excessive production of thyroid hormones, which affect metabolism but do not directly cause significant changes in calcium and phosphate levels. While it can have a variety of metabolic effects, it is not typically associated with low calcium and high phosphate. The calcium and phosphate abnormalities in hyperthyroidism are not as pronounced as in parathyroid disorders. D. Hypothyroidism Hypothyroidism is characterized by low levels of thyroid hormones, which primarily affect metabolism and growth. It does not typically lead to low calcium and high phosphate levels. Hypothyroidism may have indirect effects on calcium metabolism, but it is not a direct cause of abnormal calcium and phosphate balance.",
      "correct_choice_id": 213004,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56217131704444251/56217131704444251.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56217131704444251/56217131704444251.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90590,
      "choices": [
        {
          "id": 213007,
          "text": "Diarrhoea"
        },
        {
          "id": 213008,
          "text": "Polyuria"
        },
        {
          "id": 213009,
          "text": "Depression"
        },
        {
          "id": 213010,
          "text": "Vomiting"
        }
      ],
      "text": "Which of the following is not a feature of hypercalcemia",
      "unique_key": "Q5824390",
      "question_audio": null,
      "question_video": null,
      "map_id": 34010904,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Diarrhoea. Hypercalcemia typically presents with symptoms related to the high calcium levels in the blood, but diarrhea is not a typical feature. In fact, hypercalcemia is more often associated with constipation, as elevated calcium levels slow down the gastrointestinal motility. Thus, diarrhea is not a typical symptom of hypercalcemia. Incorrect Answers B. Polyuria Polyuria (increased urination) is a well-known feature of hypercalcemia. High calcium levels in the blood can impair the kidneys' ability to concentrate urine, leading to increased urine output. This is often seen in conditions like hyperparathyroidism and malignancy-related hypercalcemia. C. Depression Depression is a common neuropsychiatric symptom associated with hypercalcemia. Elevated calcium levels can interfere with neurotransmitter function in the brain, leading to symptoms such as confusion, lethargy, and depression. This is often referred to as \"stones, bones, abdominal groans, and psychic moans,\" which highlights the range of symptoms that can occur in hypercalcemia. D. Vomiting Vomiting is also commonly seen in hypercalcemia. High calcium levels can affect the gastrointestinal system, causing symptoms such as nausea and vomiting. It may also contribute to abdominal discomfort, which can be a common symptom in patients with severe hypercalcemia.",
      "correct_choice_id": 213007,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69663951704444264/69663951704444264.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69663951704444264/69663951704444264.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90591,
      "choices": [
        {
          "id": 213011,
          "text": "Normal saline"
        },
        {
          "id": 213012,
          "text": "Furosemide"
        },
        {
          "id": 213013,
          "text": "Dialysis"
        },
        {
          "id": 213014,
          "text": "Bisphosphonates"
        }
      ],
      "text": "A 75 year old lady with fracture neck of femur presents with two days history altered sensorium and decreased urinary output. Serum calcium is 15.5 mg/dl, urea is 140 mg/dl, creatinine is 2 mg/dl. All of the following are useful for immediate , management of hypercalcemia, Except;",
      "unique_key": "Q4069099",
      "question_audio": null,
      "question_video": null,
      "map_id": 34931004,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Bisphosphonates. Bisphosphonates are used in the long-term management of hypercalcemia, particularly in malignancy-related hypercalcemia, to inhibit bone resorption. However, they are not used in the immediate management of hypercalcemia, especially when acute interventions are needed. In this case, the patient presents with acute hypercalcemia and altered sensorium, which requires prompt measures to reduce calcium levels rapidly. Incorrect Answers A. Normal saline Normal saline (intravenous fluids) is one of the first-line treatments for acute hypercalcemia. It helps to rehydrate the patient, improve renal function, and increase calcium excretion through the kidneys. Fluids are typically administered to promote urine output and reduce serum calcium levels. B. Furosemide Furosemide (a loop diuretic) is used after adequate hydration with normal saline. It helps increase renal calcium excretion by promoting diuresis. It is effective in the management of hypercalcemia, but it should only be used after adequate hydration to avoid dehydration and further kidney injury. C. Dialysis Dialysis is indicated in cases of severe hypercalcemia (such as in patients with renal failure or when other treatments are ineffective). Dialysis is an effective method of removing excess calcium from the blood when the kidneys are not functioning adequately or when other methods of management fail to lower the calcium levels sufficiently.",
      "correct_choice_id": 213014,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63718561704444280/63718561704444280.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63718561704444280/63718561704444280.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90592,
      "choices": [
        {
          "id": 213015,
          "text": "Parathyroid hormone related protein"
        },
        {
          "id": 213016,
          "text": "Parathyroid hormone"
        },
        {
          "id": 213017,
          "text": "Interleukin-6"
        },
        {
          "id": 213018,
          "text": "Calcitonin"
        }
      ],
      "text": "Hypercalcemia associated with malignancy is most often mediated by",
      "unique_key": "Q9488037",
      "question_audio": null,
      "question_video": null,
      "map_id": 34591159,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Parathyroid hormone-related protein (PTHrP). In malignancy-associated hypercalcemia, the most common cause is the secretion of parathyroid hormone-related protein (PTHrP) by tumor cells. PTHrP acts similarly to parathyroid hormone (PTH), binding to the same receptors in bone and kidneys. This results in increased calcium resorption from bones and increased calcium reabsorption in the kidneys, leading to elevated blood calcium levels. PTHrP-mediated hypercalcemia is commonly seen in cancers like squamous cell carcinomas (especially lung and head and neck cancers), breast cancer, and renal cell carcinoma. Incorrect Answers B. Parathyroid hormone (PTH) While PTH is responsible for regulating calcium levels in the body by promoting calcium release from bones and increasing calcium reabsorption in the kidneys, primary hyperparathyroidism is the main condition where elevated PTH leads to hypercalcemia. However, in malignancy-associated hypercalcemia, PTH levels are typically low or suppressed, because the hypercalcemia is not due to excessive PTH production, but rather due to the action of PTHrP. C. Interleukin-6 (IL-6) Interleukin-6 (IL-6) is a cytokine involved in inflammation and immune response. Although it plays a role in various cancers and inflammatory conditions, it is not the primary mediator of hypercalcemia in malignancy. IL-6 can indirectly contribute to bone resorption and osteoclast activation, but PTHrP is the key mediator in malignancy-associated hypercalcemia. D. Calcitonin Calcitonin is a hormone produced by the thyroid gland that lowers blood calcium levels by inhibiting osteoclast activity in bones. It is not associated with hypercalcemia in malignancy, and its role is more in counteracting high calcium levels. Therefore, calcitonin is not a mediator of hypercalcemia in malignancy, but rather a treatment option in some cases of severe hypercalcemia.",
      "correct_choice_id": 213015,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20549831704444372/20549831704444372.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20549831704444372/20549831704444372.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90593,
      "choices": [
        {
          "id": 213019,
          "text": "Furosemide"
        },
        {
          "id": 213020,
          "text": "IV fluid"
        },
        {
          "id": 213021,
          "text": "Bisphosphonate"
        },
        {
          "id": 213022,
          "text": "Calcitonin."
        }
      ],
      "text": "A 34-year-old man is brought to the ED by his family because of lethargy. He lives alone and was not answering the phone for several days. His father has to have the lock broken to get into the house. He was found on the floor disoriented and awake only enough to say he is constipated and has abdominal pain. BP: 145/94 mm Hg; P: 86 beats/minute; Neurological: lethargic, unable to follow commands Cardiovascular: normal Abdominal: decreased bowel sounds Extremities: decreased skin turgor. Laboratory Test Results: Total calcium: 16 mg/dL (normal 9−10.5 mg/dL) BUN: 70 g/dL (normal 7−20 g/dL) Creatinine: 2.2 mg/dL (normal 0.7−1.2 mg/dL) Bicarbonate: 21mEq/L CBC, transaminases, head CT, and urine toxicology: normal.What will be the best immediate treatment",
      "unique_key": "Q3498588",
      "question_audio": null,
      "question_video": null,
      "map_id": 34042480,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) IV fluid. This patient presents with hypercalcemia (total calcium level of 16 mg/dL, normal range 9-10.5 mg/dL), renal insufficiency (BUN of 70 mg/dL and creatinine of 2.2 mg/dL), dehydration (evidenced by decreased skin turgor), and lethargy. The first-line treatment for hypercalcemia, especially when the calcium levels are significantly elevated and the patient is symptomatic (as in this case with confusion and lethargy), is aggressive IV hydration. IV fluids, particularly normal saline, help increase renal perfusion, promote calcium excretion, and dilute serum calcium levels. Given that the patient's creatinine is elevated, hydration is essential to support kidney function and promote the excretion of excess calcium. This is the best immediate treatment to start in order to manage both the hypercalcemia and renal insufficiency. Incorrect Options: A. Furosemide Furosemide, a loop diuretic, can be used to help excrete calcium after the patient has been adequately rehydrated. However, furosemide should not be used as the initial therapy for hypercalcemia, especially in a patient who is dehydrated. Diuretics can lead to further dehydration, and in this case, the priority is to first restore fluid volume with IV fluids. Only after adequate rehydration should a diuretic be considered to enhance calcium excretion. C. Bisphosphonate Bisphosphonates (e.g., pamidronate or zoledronic acid) are used for the treatment of hypercalcemia of malignancy or chronic hypercalcemia. While they work by inhibiting bone resorption and lowering calcium levels, they are not the immediate treatment in a case of acute hypercalcemia with signs of renal impairment and dehydration. The first step in managing hypercalcemia is to restore fluid volume, and bisphosphonates are typically reserved for chronic or malignancy-associated hypercalcemia. D. Calcitonin Calcitonin is another option for rapid reduction in calcium levels, particularly in severe acute hypercalcemia. It works by inhibiting bone resorption and increasing renal calcium excretion. However, its effect is usually transient and less potent than hydration, and it is often used as an adjunct to IV fluids in severe cases. IV hydration is the first step in treating this patient, and calcitonin can be considered later if calcium levels do not improve sufficiently with fluids alone.",
      "correct_choice_id": 213020,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43713781705044209/43713781705044209.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43713781705044209/43713781705044209.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90594,
      "choices": [
        {
          "id": 213023,
          "text": "Tension headache"
        },
        {
          "id": 213024,
          "text": "Multiple endocrine neoplasia type 1 (MEN1)"
        },
        {
          "id": 213025,
          "text": "Primary hyperparathyroidism"
        },
        {
          "id": 213026,
          "text": "Multiple endocrine neoplasia type 2A (MEN2A)"
        }
      ],
      "text": "A 24-year-old man presents with a persistent headache for the past few months. The headache has been gradually worsening and is unresponsive to over-the-counter medicines. He notices diminished peripheral vision while driving. He takes no medications. He denies illicit drug use but has smoked one pack of cigarettes per day since the age of 18. His medical history is significant for passage of a kidney stone last year. At that time, he was told to increase his fluid intake. Family history is positive for diabetes in his mother. His brother (age 20) has had kidney stones from too much calcium and a “low-sugar problem.” His father died of some type of tumor at age 40. Physical examination reveals a deficit in temporal fields of vision and a few subcutaneous lipomas. Laboratory results are as follows: Calcium: 11.8 mg/dL(normal 8.5-10.5) Cr: 1.1 mg/dL BUN: 17 mg/dL Glucose: 70 mg/dL Prolactin: 220 pg/L(normal 0-20) Intact parathormone: 90 pg/mL(normal 8-51) You suspect a pituitary tumor and order an MRI which reveals a 0.7 cm pituitary mass. Based on this patient’s presentation, which of the following is the most probable diagnosis?",
      "unique_key": "Q4928143",
      "question_audio": null,
      "question_video": null,
      "map_id": 34091675,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Multiple endocrine neoplasia type 1 (MEN1) This patient presents with a combination of symptoms and lab findings that strongly suggest MEN1, a genetic disorder characterized by tumors in multiple endocrine glands. The key features of MEN1 in this patient are: Pituitary tumor: The MRI revealed a pituitary mass, which can cause various symptoms such as headache and visual changes (e.g., peripheral vision loss, also known as bitemporal hemianopia). In MEN1, pituitary adenomas are common and may lead to excess hormone secretion, such as prolactin (elevated in this patient). Hypercalcemia: The elevated calcium level (11.8 mg/dL) suggests hyperparathyroidism, another hallmark of MEN1, which is caused by parathyroid adenomas. MEN1 commonly leads to primary hyperparathyroidism due to parathyroid gland hyperplasia or adenomas, resulting in hypercalcemia. Subcutaneous lipomas: These are a common manifestation of MEN1. Lipomas are benign fatty tumors found in the skin and are often present in patients with MEN1. Family history: The patient's family history of kidney stones and a \"low-sugar problem\" (potential hypoglycemia, which can be associated with insulinomas, another tumor seen in MEN1) further raises suspicion for MEN1. MEN1 is inherited in an autosomal dominant manner, and a family history of early-onset tumors (father with a tumor at age 40) is consistent with this diagnosis. Thus, the combination of pituitary adenoma, hypercalcemia, lipomas, and a family history of endocrine tumors points to MEN1 as the most likely diagnosis. Incorrect Responses: A. Tension headache – Incorrect: Tension headaches are typically characterized by bilateral, mild to moderate pain that is often described as a \"tight band\" around the head. The patient's headache is persistent, worsening, and associated with more severe symptoms like visual changes (diminished peripheral vision), which are not typical of a tension headache. Additionally, the patient has significant endocrine abnormalities (e.g., elevated prolactin and calcium), making a diagnosis of tension headache unlikely. C. Primary hyperparathyroidism – Incorrect: While primary hyperparathyroidism (characterized by elevated calcium levels) is a significant finding in this patient, it is not the sole diagnosis. Primary hyperparathyroidism often presents with hypercalcemia and may cause symptoms such as fatigue, weakness, and kidney stones. However, the presence of a pituitary mass, subcutaneous lipomas, and a family history of endocrine tumors points toward MEN1, in which primary hyperparathyroidism is just one component of a broader syndrome. D. Multiple endocrine neoplasia type 2A (MEN2A) – Incorrect: MEN2A is a genetic disorder that primarily involves medullary thyroid cancer, pheochromocytomas, and primary hyperparathyroidism. While primary hyperparathyroidism is a feature of MEN2A, the key component of this patient's presentation—pituitary adenoma—is not a characteristic of MEN2A. MEN2A does not typically cause pituitary tumors, so this diagnosis is less likely.",
      "correct_choice_id": 213024,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58416141705045455/58416141705045455.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58416141705045455/58416141705045455.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90595,
      "choices": [
        {
          "id": 213027,
          "text": "Hypoparathyroidism"
        },
        {
          "id": 213028,
          "text": "Estrogen deficiency"
        },
        {
          "id": 213029,
          "text": "Primary biliary cirrhosis"
        },
        {
          "id": 213030,
          "text": "Celiac disease"
        }
      ],
      "text": "A 65-year-old white woman presents for an annual examination. She feels well except for occasional nocturnal leg cramp and mild abdominal bloating. She takes a multivitamin and a supplement containing 600 mg calcium carbonate and 200 international units of vitamin D twice daily. She takes no prescription medications. Physical examination is unremarkable for her age. In completing the appropriate screening tests, you order a dual-x-ray absorptiometry (DEXA) to evaluate whether the patient has osteoporosis. DEXA results reveal a T-score of –3.0 at the total hip and –2.7 at the femoral neck (osteoporosis: less than –2.5). Since her Z-score is –2.0, you proceed with an evaluation of secondary osteoporosis. Laboratory evaluation reveals Calcium: 8.2 mg/dL Cr: 1.0 mg/dL BUN: 19 mg/dL Glucose: 98 mg/dL 25, OH vitamin D: 12 ng/mL(optimal >30) Liver enzymes including alkaline phosphatase: normal WBC: 7700/μL Hg: 10.3 g/dL HCT: 32 g/dL MCV 68 PLT: 255,000/μL What is the likely cause of her osteoporosis?",
      "unique_key": "Q8238242",
      "question_audio": null,
      "question_video": null,
      "map_id": 34223059,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Celiac disease. This patient's osteoporosis with a T-score of –3.0 at the total hip and –2.7 at the femoral neck, coupled with the low vitamin D level (12 ng/mL), suggests secondary osteoporosis, likely due to malabsorption. The low vitamin D level is a key finding that may be related to malabsorption, which is common in celiac disease. Celiac disease is a chronic autoimmune disorder that affects the small intestine, leading to malabsorption of nutrients, including vitamin D and calcium. Osteoporosis is a well-known complication of celiac disease due to poor absorption of essential nutrients. Additionally, this patient has microcytic anemia (MCV 68), which could indicate iron deficiency, another common finding in celiac disease due to impaired nutrient absorption. Therefore, the most likely cause of her osteoporosis is celiac disease, and she should be further evaluated for this condition with serologic tests (e.g., anti-tissue transglutaminase antibodies). Incorrect Responses: A. Hypoparathyroidism – Incorrect: Hypoparathyroidism is characterized by low calcium levels due to decreased parathyroid hormone (PTH) secretion. However, this patient's calcium level is 8.2 mg/dL, which is within the normal range. Additionally, hypoparathyroidism typically causes hypocalcemia, not osteoporosis in isolation. The patient’s calcium level and normal kidney function do not support hypoparathyroidism as the cause of her osteoporosis. B. Estrogen deficiency – Incorrect: While estrogen deficiency due to menopause is a common cause of osteoporosis, especially in postmenopausal women, this patient is 65 years old and it is likely that her estrogen levels have already significantly decreased. However, secondary causes of osteoporosis, such as celiac disease, should be considered, particularly in the presence of other risk factors like low vitamin D and microcytic anemia. Moreover, the patient's normal physical examination and lack of typical menopausal symptoms make estrogen deficiency a less likely primary cause in this case. C. Primary biliary cirrhosis – Incorrect: Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease that can lead to osteoporosis, but it is typically associated with other clinical findings, including elevated liver enzymes and bilirubin levels, which are not present in this patient. Her liver enzymes, including alkaline phosphatase, are normal, making PBC an unlikely cause of her osteoporosis. Although PBC can lead to secondary osteoporosis, the absence of other typical features and lab findings makes it less likely in this patient.",
      "correct_choice_id": 213030,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69038211705045626/69038211705045626.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69038211705045626/69038211705045626.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90596,
      "choices": [
        {
          "id": 213031,
          "text": "Osteoblastic lesions of bone"
        },
        {
          "id": 213032,
          "text": "Cystic bone lesions"
        },
        {
          "id": 213033,
          "text": "Prolonged qt interval ecg"
        },
        {
          "id": 213034,
          "text": "Orthostatic hypotension"
        }
      ],
      "text": "A 42-year-old woman presented for routine health check up. On examination BP-120/70 mmHg,pulse-84/min, chest-clear, CVS-normal. Blood tests showed serum calcium level of 12 mg/dL(normal 8.5-10.5 mg/dl). Further investigations reveal a parathormone (PTH) level of 750 pg/mL (normal 230–630 pg/mL). Which of the following findings is also associated with this disorder?",
      "unique_key": "Q5999995",
      "question_audio": null,
      "question_video": null,
      "map_id": 34483660,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Cystic bone lesions. The patient’s presentation suggests primary hyperparathyroidism, indicated by an elevated serum calcium level (12 mg/dL) and a high parathyroid hormone (PTH) level (750 pg/mL), which is above the normal range (230–630 pg/mL). In primary hyperparathyroidism, the overproduction of parathyroid hormone (PTH) leads to increased calcium levels by increasing calcium reabsorption from the kidneys, stimulating osteoclast activity (bone resorption), and increasing the release of calcium from the bones. The abnormal bone metabolism associated with hyperparathyroidism often results in osteitis fibrosa cystica, a condition characterized by cystic bone lesions. These cystic lesions are formed due to excessive bone resorption and the subsequent formation of fibrous tissue in place of normal bone. This is a common finding in patients with hyperparathyroidism, especially when the disease is longstanding and untreated. Incorrect Responses: A. Osteoblastic lesions of bone – Incorrect: Osteoblastic lesions are typically associated with bone formation rather than resorption. In hyperparathyroidism, the predominant effect is bone resorption due to increased osteoclast activity, which leads to bone loss and cystic changes, rather than the formation of new bone (osteoblastic lesions). Osteoblastic lesions are more commonly seen in conditions like metastatic cancer to bone, particularly from prostate or breast cancer, not in primary hyperparathyroidism. C. Prolonged QT interval ECG – Incorrect: A prolonged QT interval on ECG is generally associated with hypocalcemia (low calcium levels), not hypercalcemia. Hypercalcemia, as seen in this patient, typically shortens the QT interval, not lengthens it. Elevated calcium levels can decrease the duration of the QT interval, and this can be an important finding when assessing a patient with hypercalcemia on ECG. D. Orthostatic hypotension – Incorrect: Orthostatic hypotension is a condition characterized by a significant drop in blood pressure when a person stands up from a sitting or lying position. It is usually associated with dehydration, blood loss, or certain neurological conditions. Primary hyperparathyroidism does not directly cause orthostatic hypotension, and the patient in this case has a normal blood pressure (120/70 mmHg). Orthostatic hypotension would not be a typical finding associated with primary hyperparathyroidism.",
      "correct_choice_id": 213032,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40091741705047389/40091741705047389.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40091741705047389/40091741705047389.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90597,
      "choices": [
        {
          "id": 213035,
          "text": "Osteomalacia"
        },
        {
          "id": 213036,
          "text": "Osteogenic sarcoma"
        },
        {
          "id": 213037,
          "text": "Vitamin D deficiency"
        },
        {
          "id": 213038,
          "text": "Paget’s disease of bone"
        }
      ],
      "text": "A 63-year-old asymptomatic woman comes for routine health check up.There is no significant past medical history.She follows a good exercise regimen.She is not taking any medications or supplements.On examination BP-130/60 mmHg,pulse is 80/min and is bounding in nature.Lab tests showed high alkaline phosphatase (ALP) level,other liver function tests are normal. X-rays of the pelvis show multiple porotic and sclerotic lesions with characteristic whorls of trabeculation. Her excretion of urinary hydroxyproline is also elevated. Which of the following is the most likely diagnosis?",
      "unique_key": "Q2448957",
      "question_audio": null,
      "question_video": null,
      "map_id": 34014048,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Paget’s disease of bone. This 63-year-old woman presents with a bounding pulse, high alkaline phosphatase (ALP), porotic and sclerotic lesions on pelvis X-rays, and elevated urinary hydroxyproline, which are all characteristic findings of Paget’s disease of bone. In Paget’s disease, abnormal bone remodeling leads to areas of increased bone turnover and structural changes. The whorled trabeculation seen on the X-ray is highly suggestive of this condition. Paget's disease typically presents in asymptomatic patients during routine checkups and is often detected by an elevated ALP level. Incorrect Answers: A. Osteomalacia: Osteomalacia is a condition characterized by defective mineralization of bone due to vitamin D deficiency, leading to bone pain, muscle weakness, and fractures. However, the elevated ALP and whorled trabeculation seen in the X-rays are not typical of osteomalacia. In osteomalacia, X-rays typically show bone thinning and pseudofractures, not the characteristic sclerotic lesions seen here. Additionally, the lack of other signs of vitamin D deficiency makes this diagnosis less likely. B. Osteogenic sarcoma: Osteogenic sarcoma (osteosarcoma) is a malignant bone tumor, typically seen in younger patients and characterized by aggressive bone pain, swelling, and radiographic findings of new bone formation. The presentation of sclerotic lesions and whorled trabeculation in this case, along with a normal physical exam (other than the bounding pulse), makes osteosarcoma less likely. Moreover, osteosarcoma would present with elevated bone pain and would not typically cause an elevated ALP without associated abnormal findings on bone imaging. C. Vitamin D deficiency: Vitamin D deficiency can lead to osteomalacia, as mentioned above, which is a different process than Paget’s disease of bone. Although vitamin D deficiency can cause elevated ALP levels due to defective mineralization, it would not lead to the specific trabecular bone changes or sclerotic lesions observed in this patient’s X-ray. Furthermore, there is no clinical or lab evidence (such as low calcium or phosphate) supporting vitamin D deficiency in this patient.",
      "correct_choice_id": 213038,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54290931705047913/54290931705047913.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54290931705047913/54290931705047913.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90598,
      "choices": [
        {
          "id": 213039,
          "text": "Low vitamin D, low phosphate, high PTH"
        },
        {
          "id": 213040,
          "text": "Low vitamin D, low phosphate, low PTH"
        },
        {
          "id": 213041,
          "text": "Low vitamin D, high phosphate, low PTH"
        },
        {
          "id": 213042,
          "text": "Normal vitamin D, low phosphate, high PTH"
        }
      ],
      "text": "A 30-year-old man presented with symptoms of weakness with numbness and tingling in his hands. He also complaint of perioral numbness. Past medical history is not significant for diabetes, hypertension and hypothyroidism. He doesn’t take alcohol. The physical examination showed Chvostek sign positive. Blood tests revealed calcium as 7.4 mg/dL (normal 8.5–10.5 mg/dL).You are suspecting vitamin D deficiency as a cause of hypocalcemia. Which of the following additional serum values is most consistent with the diagnosis of vitamin D deficiency?",
      "unique_key": "Q7984158",
      "question_audio": null,
      "question_video": null,
      "map_id": 34439506,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Low vitamin D, low phosphate, high PTH. In vitamin D deficiency, the decreased levels of vitamin D lead to decreased intestinal calcium absorption, resulting in hypocalcemia. To compensate for the low calcium levels, the parathyroid glands increase the secretion of parathyroid hormone (PTH), which then increases calcium resorption from the bones and reduces phosphate reabsorption by the kidneys. This results in elevated PTH, low calcium, and low phosphate levels, which is a classic laboratory finding in vitamin D deficiency. The patient’s symptoms of numbness, tingling, and positive Chvostek sign are also consistent with hypocalcemia, supporting this diagnosis. Incorrect Answers: B. Low vitamin D, low phosphate, low PTH: In vitamin D deficiency, low phosphate is typically seen due to reduced renal phosphate reabsorption in response to elevated PTH. However, low PTH is not typically associated with vitamin D deficiency. Instead, high PTH is observed as the body attempts to compensate for hypocalcemia. C. Low vitamin D, high phosphate, low PTH: This pattern is inconsistent with vitamin D deficiency. High phosphate would not typically be seen in vitamin D deficiency, as PTH normally reduces phosphate reabsorption in the kidneys. Additionally, the low PTH would not explain the hypocalcemia in this context. D. Normal vitamin D, low phosphate, high PTH: If the vitamin D level were normal, the cause of hypocalcemia would not likely be vitamin D deficiency. The presence of low phosphate and high PTH suggests a different etiology of hypocalcemia, such as secondary hyperparathyroidism, but this is not typical for vitamin D deficiency, which is usually associated with low vitamin D levels.",
      "correct_choice_id": 213039,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65949001705047929/65949001705047929.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65949001705047929/65949001705047929.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90599,
      "choices": [
        {
          "id": 213043,
          "text": "Zollinger-Ellison syndrome"
        },
        {
          "id": 213044,
          "text": "Insulinoma"
        },
        {
          "id": 213045,
          "text": "Primary hyperparathyroidism"
        },
        {
          "id": 213046,
          "text": "Acromegaly"
        }
      ],
      "text": "A 50-year-old male presented to OPD with complaints of pain epigastrium for many years. Intermittently he complaint of episodes of tremors and sweating with low plasma glucose levels. He gives family history of some neuroendocrine tumor in elder brother. On examination-no abnormality detected. Lab tests revealed high levels of PTH and c peptide levels. You are suspecting a diagnosis of MEN 1, Which of the following is the most common manifestation of multiple endocrine neoplasia, type I (MEN I)?",
      "unique_key": "Q7619811",
      "question_audio": null,
      "question_video": null,
      "map_id": 34719515,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Primary hyperparathyroidism Explanation of Correct Answer: Multiple endocrine neoplasia type I (MEN 1) is an autosomal dominant syndrome characterized by tumors in the parathyroid glands, pancreas, and anterior pituitary. The most common manifestation of MEN 1 is primary hyperparathyroidism, which occurs due to hyperplasia or adenomas in the parathyroid glands. This leads to elevated parathyroid hormone (PTH) levels and hypercalcemia. Clinical symptoms may include nephrolithiasis, fatigue, bone pain, and gastrointestinal complaints. The patient's lab findings of high PTH levels and family history of neuroendocrine tumors further support this diagnosis. Approximately 90% of MEN 1 cases present with primary hyperparathyroidism, making it the most common and earliest manifestation of the syndrome. Explanation of Incorrect Answers: A. Zollinger-Ellison syndrome: This is incorrect because Zollinger-Ellison syndrome, caused by gastrin-secreting tumors (gastrinomas), is a manifestation of MEN 1 but occurs less frequently than primary hyperparathyroidism. Gastrinomas are seen in about 40% of MEN 1 patients and often lead to peptic ulcers due to excessive gastric acid secretion. While this patient may have epigastric pain suggestive of Zollinger-Ellison syndrome, primary hyperparathyroidism remains the most common and defining feature. B. Insulinoma: This is incorrect because insulinomas, which are pancreatic beta-cell tumors causing hypoglycemia due to excess insulin secretion, are less common than primary hyperparathyroidism in MEN 1. Insulinomas are seen in about 10%–20% of MEN 1 patients. This patient's history of hypoglycemia could be due to an insulinoma, but the hallmark feature of MEN 1 is primary hyperparathyroidism. D. Acromegaly: This is incorrect because acromegaly, caused by a growth hormone-secreting pituitary adenoma, is a less frequent manifestation of MEN 1. Pituitary tumors occur in about 30%–40% of MEN 1 patients, with prolactinomas being more common than growth hormone-secreting tumors. Acromegaly is not the most common manifestation of MEN 1.",
      "correct_choice_id": 213045,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2439321705048053/2439321705048053.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2439321705048053/2439321705048053.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90600,
      "choices": [
        {
          "id": 213047,
          "text": "Decreased CAD"
        },
        {
          "id": 213048,
          "text": "Decreased breast cancer risk"
        },
        {
          "id": 213049,
          "text": "Reduced veno-thromboembolism"
        },
        {
          "id": 213050,
          "text": "Decreased osteoporosis-related fractures"
        }
      ],
      "text": "A 51-year-old woman presented in OPD with complaints of irregular periods for the past 6 months. Periods are delayed by 15-20 days with spotting. She also has symptoms of hot flashes and night sweats. Her physical examination is normal. Blood tests are normal for plasma glucose, CBC, thyroid functions and liver function test. You decided to start Hormone replacement therapy (HRT) for her symptoms. Which of the following is the most likely additional benefit of HRT?",
      "unique_key": "Q3268258",
      "question_audio": null,
      "question_video": null,
      "map_id": 34470292,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Decreased osteoporosis-related fractures Explanation of Correct Answer: Hormone replacement therapy (HRT) is commonly used in peri- and postmenopausal women to alleviate symptoms such as hot flashes, night sweats, and irregular periods. An additional benefit of HRT is its protective effect on bone health. Estrogen in HRT helps reduce bone resorption by inhibiting osteoclast activity, thereby maintaining bone density and decreasing the risk of osteoporosis-related fractures, particularly in the hip and spine. This is especially important for postmenopausal women, who are at an increased risk of osteoporosis due to declining estrogen levels. Numerous studies have confirmed that HRT significantly reduces fracture risk, making it a primary additional benefit of therapy. Explanation of Incorrect Answers: A. Decreased CAD (Coronary Artery Disease): This is incorrect because while estrogen may improve lipid profiles by increasing HDL and decreasing LDL levels, large studies such as the Women’s Health Initiative (WHI) have shown that HRT does not reduce the risk of coronary artery disease (CAD). In fact, HRT may increase the risk of cardiovascular events in certain populations, particularly in older women or those who start HRT many years after menopause. Thus, HRT is not recommended as a preventive measure for CAD. B. Decreased breast cancer risk: This is incorrect because HRT, particularly combined estrogen-progestin therapy, has been associated with a slight increase in the risk of breast cancer with long-term use (more than 3-5 years). Estrogen-only therapy in women who have undergone hysterectomy has a lower or neutral risk. However, overall, HRT is not protective against breast cancer and should be used cautiously in women at high risk for breast cancer. C. Reduced veno-thromboembolism (VTE): This is incorrect because HRT is associated with an increased risk of venous thromboembolism, particularly with oral formulations. Estrogen increases coagulation factor production, leading to a hypercoagulable state. The risk is highest in the first year of use and is dose-dependent. Non-oral forms of HRT, such as transdermal patches, carry a lower risk but do not eliminate it entirely.",
      "correct_choice_id": 213050,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26380121705048069/26380121705048069.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26380121705048069/26380121705048069.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90601,
      "choices": [
        {
          "id": 213051,
          "text": "Enlargement"
        },
        {
          "id": 213052,
          "text": "Spasm"
        },
        {
          "id": 213053,
          "text": "Increased strength"
        },
        {
          "id": 213054,
          "text": "Myositis"
        }
      ],
      "text": "A 53-year-old woman develops headache, increased hand and foot size. On examination, she has spade like hands, coarsened facial features, and a gap between her incisors. Her blood pressure is 155/85 mm Hg and pulse 80/min, macroglossia and thyromegaly is present.cardiac apical beat is sustained with normal heart sounds. Which of the following is the most likely effect of this syndrome on the muscles?",
      "unique_key": "Q7396330",
      "question_audio": null,
      "question_video": null,
      "map_id": 34208797,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Enlargement Explanation of Correct Answer: The clinical features described in this 53-year-old woman are highly suggestive of acromegaly, a condition caused by excessive growth hormone (GH) secretion, typically due to a pituitary adenoma. Common manifestations of acromegaly include enlargement of the hands and feet (spade-like hands), coarsened facial features (such as a prominent jaw and a gap between the incisors), macroglossia (enlarged tongue), and thyromegaly (enlarged thyroid). The effect of excessive growth hormone on various tissues, including muscle tissue, is hypertrophy or enlargement. In acromegaly, GH promotes the growth of tissues by stimulating the liver to produce insulin-like growth factor 1 (IGF-1), which in turn promotes cell growth and tissue enlargement. This leads to muscle hypertrophy, particularly in the proximal muscles. The muscles themselves become enlarged as a result of prolonged exposure to elevated levels of GH, even though there may not necessarily be a corresponding increase in muscle strength. Explanation of Incorrect Answers: B. Spasm: Muscle spasm refers to an involuntary contraction of a muscle, typically due to electrolyte imbalances, dehydration, or nerve-related issues. There is no indication in this patient’s presentation of spasm or other symptoms that would suggest a neuromuscular disorder or spasm. The enlargement of muscles in acromegaly is a more likely explanation for her muscle-related symptoms. C. Increased strength: While acromegaly results in muscle enlargement due to tissue hypertrophy, increased muscle strength is not a typical finding. Despite the muscle enlargement, acromegaly is more commonly associated with muscle weakness or decreased strength, especially in the proximal muscles. Therefore, increased strength is not a direct effect of the syndrome, making this option incorrect. D. Myositis: Myositis refers to inflammation of the muscles, typically caused by autoimmune diseases, infections, or drug reactions. This patient’s symptoms, including muscle enlargement, are more indicative of hypertrophy due to growth hormone excess, rather than inflammation. There is no evidence in her history or physical exam to suggest muscle inflammation or myositis.",
      "correct_choice_id": 213051,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45726441705048106/45726441705048106.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45726441705048106/45726441705048106.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90602,
      "choices": [
        {
          "id": 213055,
          "text": "Hyperphosphatemia"
        },
        {
          "id": 213056,
          "text": "Low 1,25(OH)2 vitamin D levels"
        },
        {
          "id": 213057,
          "text": "Alopecia"
        },
        {
          "id": 213058,
          "text": "Osteoporosis"
        }
      ],
      "text": "A 7-year-old boy complaint of bone pains. His parents noticed bowing of legs. His elder brother has similar bone disorder. There is alopecia on clinical examination .X ray showed demineralized bones with pseudo fractures. Serum calcium and phosphorus are low. PTH is raised. Physiologic doses of vitamin D do not result in improvement. Which of the following is most likely to be associated with this syndrome?",
      "unique_key": "Q6655546",
      "question_audio": null,
      "question_video": null,
      "map_id": 34967442,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Alopecia Explanation of Correct Answer: The clinical presentation of this 7-year-old boy with bone pain, bowing of legs, demineralized bones, pseudo fractures, low calcium and phosphorus, and elevated PTH is highly suggestive of X-linked hypophosphatemic rickets (XLH), a hereditary disorder. This condition is caused by mutations in the PHEX gene, which leads to impaired phosphate reabsorption in the kidneys, resulting in hypophosphatemia and defective bone mineralization. The additional feature of alopecia is a key finding in some forms of rickets, particularly in XLH. In XLH, while vitamin D treatment typically corrects calcium and phosphorus deficiencies, it does not always correct the underlying renal phosphate wasting, and therefore bone deformities may persist. In some cases, alopecia (hair loss) is reported as part of the broader systemic manifestations of the disorder. Explanation of Incorrect Answers: A. Hyperphosphatemia: This child has low phosphorus levels, not high. In X-linked hypophosphatemic rickets, phosphate wasting in the kidneys leads to hypophosphatemia, not hyperphosphatemia. Elevated phosphate levels are not characteristic of this condition, making this answer incorrect. B. Low 1,25(OH)2 vitamin D levels: In rickets caused by vitamin D deficiency, you would expect low levels of 1,25(OH)2 vitamin D. However, in X-linked hypophosphatemic rickets, the issue is not a lack of vitamin D but impaired phosphate handling by the kidneys. While vitamin D supplementation does not improve the condition significantly, it does not lead to the low 1,25(OH)2 vitamin D levels seen in nutritional vitamin D deficiency. Therefore, this option is incorrect. D. Osteoporosis: While osteomalacia (bone softening) is a hallmark of rickets, osteoporosis (a condition characterized by bone loss and decreased bone density) is not typically associated with X-linked hypophosphatemic rickets in children. In this disorder, the bones are demineralized but are not characteristic of the osteoporotic changes seen in adults or in disorders specifically causing osteoporosis. Therefore, this answer is incorrect.",
      "correct_choice_id": 213057,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42414711705048120/42414711705048120.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42414711705048120/42414711705048120.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90603,
      "choices": [
        {
          "id": 213059,
          "text": "Hyperphosphatemia"
        },
        {
          "id": 213060,
          "text": "Hypoparathyroidism"
        },
        {
          "id": 213061,
          "text": "Decreased vitamin D"
        },
        {
          "id": 213062,
          "text": "Hypercalcemia"
        }
      ],
      "text": "A 27-year-old woman complains of pain in her left shin. Her sunlight exposure is minimal. X-rays of the leg reveal a stress fracture of the tibia, decreased cortical bone density, and increased radiolucency. She is suspected of having osteomalacia (impaired mineralization of bone matrix). Which of the following is the most common biochemical manifestation of osteomalacia?",
      "unique_key": "Q5872353",
      "question_audio": null,
      "question_video": null,
      "map_id": 34175577,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Decreased vitamin D Explanation of Correct Answer: Osteomalacia is characterized by impaired mineralization of bone matrix due to a deficiency in vitamin D. Vitamin D plays a crucial role in the absorption of calcium and phosphate from the intestines, which are necessary for normal bone mineralization. In osteomalacia, inadequate vitamin D levels lead to low calcium and phosphate levels, resulting in defective bone mineralization, as evidenced by decreased cortical bone density and increased radiolucency on X-rays, as seen in this patient. This patient has minimal sunlight exposure, which is a common risk factor for vitamin D deficiency, as sunlight is the primary source for the synthesis of vitamin D in the skin. Therefore, the most common biochemical manifestation of osteomalacia is decreased vitamin D levels. Explanation of Incorrect Answers: A. Hyperphosphatemia: In osteomalacia, phosphate levels are typically low or normal, not elevated. The low levels of vitamin D reduce the intestinal absorption of phosphate, leading to hypophosphatemia. Hyperphosphatemia is not a typical finding in osteomalacia, so this option is incorrect. B. Hypoparathyroidism: Hypoparathyroidism refers to low parathyroid hormone (PTH) levels, which can result in hypocalcemia and impaired bone remodeling. However, osteomalacia is typically due to a deficiency in vitamin D rather than a problem with parathyroid hormone regulation. In osteomalacia, PTH levels may actually be elevated as a compensatory mechanism to try to raise calcium levels. Thus, hypoparathyroidism is not associated with osteomalacia. D. Hypercalcemia: In osteomalacia, the calcium levels are usually normal or low because of impaired absorption due to vitamin D deficiency. Hypercalcemia (elevated calcium levels) is not typical of osteomalacia. Instead, secondary hyperparathyroidism (elevated PTH) may occur as a compensatory mechanism to attempt to increase calcium levels in the blood, but calcium itself will generally remain low or normal. Therefore, hypercalcemia is not a common manifestation of osteomalacia.",
      "correct_choice_id": 213061,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33379701705048166/33379701705048166.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33379701705048166/33379701705048166.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 90604,
      "choices": [
        {
          "id": 213063,
          "text": "Scleroderma"
        },
        {
          "id": 213064,
          "text": "Gout"
        },
        {
          "id": 213065,
          "text": "Secondary hyperparathyroidism"
        },
        {
          "id": 213066,
          "text": "Pseudogout"
        }
      ],
      "text": "A 65-year-old woman was diagnosed as case of chronic kidney disease. She is now put on hemodialysis in view of refractory metabolic acidosis and fluid overload. She complains of pain in the hands. On examination, the joints are normal with no inflammation or tenderness on palpation. Lab values reveal a low calcium, high phosphate, and high PTH level. What is the most likely diagnosis",
      "unique_key": "Q4723955",
      "question_audio": null,
      "question_video": null,
      "map_id": 34552407,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Secondary hyperparathyroidism Explanation of Correct Answer: In patients with chronic kidney disease (CKD), secondary hyperparathyroidism (SHPT) is a common complication due to the kidneys' inability to excrete phosphate and activate vitamin D, leading to low calcium levels. This stimulates the parathyroid glands to secrete more parathyroid hormone (PTH) in an attempt to increase calcium levels. The elevated PTH, low calcium, and high phosphate levels in this patient are classic findings of secondary hyperparathyroidism. The patient also complains of pain in the hands, which can be due to osteodystrophy (bone changes due to CKD), including bone pain and joint stiffness. This condition occurs in a significant proportion of CKD patients and is managed by controlling phosphate levels, supplementing calcium, and sometimes using medications that lower PTH. Explanation of Incorrect Answers: A. Scleroderma: Scleroderma is an autoimmune disease characterized by skin thickening, Raynaud's phenomenon, and organ involvement (such as lungs, heart, and kidneys). The patient's presentation does not show typical findings of scleroderma such as skin changes or Raynaud’s phenomenon. Furthermore, the lab values of low calcium, high phosphate, and high PTH are not characteristic of scleroderma, which does not commonly cause these specific biochemical abnormalities. Therefore, scleroderma is unlikely in this case. B. Gout: Gout is caused by the deposition of monosodium urate crystals in joints due to hyperuricemia. While pain in the joints could suggest a crystal-induced arthropathy like gout, the lab findings of low calcium, high phosphate, and high PTH are not consistent with gout. Gout is more associated with elevated uric acid levels, not changes in calcium or phosphate metabolism, making this diagnosis unlikely in this patient. D. Pseudogout: Pseudogout is caused by the deposition of calcium pyrophosphate crystals in joints, leading to inflammation and pain, often affecting the knees and wrists. While the patient complains of pain in the hands, there is no mention of joint inflammation or tenderness, which is typically present in pseudogout. Additionally, the biochemical abnormalities in this case (low calcium, high phosphate, high PTH) are not characteristic of pseudogout. Pseudogout is not associated with the same metabolic changes seen in secondary hyperparathyroidism.",
      "correct_choice_id": 213065,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31910571705048281/31910571705048281.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31910571705048281/31910571705048281.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}